N14.3 Nephropathy induced by heavy metals

Name of the Condition

• Nephropathy Induced by Heavy Metals
• ICD-10 Code: N14.3

Summary

Nephropathy induced by heavy metals is a kidney disorder resulting from exposure to toxic heavy metals, leading to damage to renal tubules and interstitial tissue. This condition can impair kidney function and may present as acute or chronic kidney injury, depending on the duration and intensity of exposure. Identifying the causative metal is critical for guiding treatment and preventing further renal damage.

Causes

This condition is caused by the direct toxic effects of heavy metals—such as lead, mercury, cadmium, or arsenic—on renal tubular cells. The damage occurs through mechanisms like oxidative stress, inflammation, or disruption of cellular processes. Exposure may be occupational, environmental, or iatrogenic (e.g., from contaminated supplements or medical devices).

Risk Factors

• Occupational exposure: Work in industries involving heavy metals (e.g., mining, smelting, battery manufacturing).
• Environmental exposure: Living near contaminated sites or using water/food sources with high metal levels.
• Iatrogenic exposure: Use of unregulated supplements or medical products containing heavy metals.
• Pre-existing kidney disease: Reduced renal reserve may increase susceptibility to toxicity.

Symptoms

• Fatigue or weakness.
• Flank pain or dull aching in the kidney area.
• Hematuria (blood in urine).
• Proteinuria (excess protein in urine).
• Reduced urine output or changes in urine color.
• Swelling in the legs, ankles, or face (edema).
• Nausea or vomiting.

Diagnosis

Diagnosis involves a combination of clinical evaluation, exposure history, and laboratory tests. Urinalysis may show blood or protein, while blood tests assess kidney function (e.g., creatinine, BUN). Imaging (e.g., ultrasound) can evaluate kidney structure, and heavy metal levels in blood or urine confirm exposure. A kidney biopsy may be performed to assess tissue damage.

Treatment Options

Treatment focuses on removing the source of exposure and supporting kidney function. Chelation therapy (e.g., with agents like dimercaptosuccinic acid) may be used to bind and eliminate heavy metals. Supportive care includes managing fluid balance, electrolytes, and blood pressure. In severe cases, dialysis may be necessary to address acute kidney failure.

Prognosis and Follow-Up

Prognosis depends on the extent of kidney damage and timely removal of the toxic agent. Early intervention can improve outcomes, but chronic exposure may lead to irreversible renal scarring. Regular monitoring of kidney function and heavy metal levels is essential to track recovery and prevent recurrence.

Complications

• Chronic kidney disease or renal failure.
• Hypertension (high blood pressure).
• Electrolyte imbalances.
• Anemia due to reduced erythropoietin production.
• Increased risk of cardiovascular events.

Lifestyle & Prevention

• Avoid exposure to known heavy metal sources (e.g., contaminated water, industrial sites).
• Use protective equipment in occupational settings.
• Ensure supplements and medications are from reputable sources.
• Maintain adequate hydration to support kidney function.
• Follow up with healthcare providers if exposure is suspected.

When to Seek Professional Help

Seek medical attention if you experience persistent fatigue, changes in urine (e.g., blood, foaminess), swelling, or unexplained nausea—especially if you have a history of heavy metal exposure. Prompt evaluation is critical to prevent irreversible kidney damage.

Tips for Medical Coders

Document the specific heavy metal involved (e.g., lead, mercury) and the source of exposure (occupational, environmental, iatrogenic) to support coding accuracy. Include details on diagnostic tests (e.g., heavy metal levels, biopsy) and treatment (e.g., chelation therapy) to clarify the clinical context. Ensure the code aligns with the patient’s documented exposure history and renal findings.